Gem Science Medical Clinic
- IV Therapy
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
Indianapolis, IN
Indianapolis has a major Midwestern healthcare hub with Eli Lilly anchored nearby, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across Carmel, Meridian-Kessler, Fishers, and Broad Ripple range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the IU Health, Community Health Network, and Eskenazi network. The scene here skews toward academic-trained physicians running longevity practices at Midwestern price points. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Indianapolis clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.
Regulatory context
Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. The FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list during 2023 and 2024, restricting what 503A pharmacies can source. Section 503A covers traditional patient-specific compounding; Section 503B covers FDA-registered outsourcing facilities held to cGMP.
The Indiana Board of Pharmacy inspects compounding facilities under USP standards and publishes disciplinary actions. Non-resident pharmacies shipping peptides into Indiana must hold a non-resident pharmacy permit. The Professional Licensing Agency coordinates inspections with the Indiana State Department of Health where relevant.